Michael Dudley

Boston, Massachusetts, United States
R. Michael Dudley has served as Co-Founder, Chief Executive Officer and Director of TransCode
since January 2016. Prior to founding TransCode, Mr. Dudley co-founded and was CEO and Chairman of Artemes Technologies, Inc. a Boston-based drug delivery technology company that specialized in
customized drug delivery systems for injectable medications. Previously, he held executive level leadership positions with industry leaders in medical devices for imaging, drug delivery, and surgical applications. He has additional experience in the diagnostic industry and web based
clinical trial applications. Mr. Dudley began his career as a Cancer Research Associate at Harvard Medical School conducting immunology and biochemistry research in the field of tumor-associated blocking factors in breast cancer from April 1973 to December 1975. Mr. Dudley obtained a B.S. degree in Biological Sciences with a concentration in Immunology and Chemistry from Kent State University in Kent, Ohio.
Speaking In
2:30 PM - 2:45 PM (PDT)
Monday, June 13
As the RNA Oncology Company, TransCode is committed to defeating cancer through the intelligent…